Call Us Today:
949.200.1600

Atypical Fibroxanthoma-AFX

Home > Diagnosis > Uncommon Skin Cancers > AFX

Atypical Fibroxanthoma Treatment

ABOUT ATYPICAL FIBROXANTHOMA (AFX)

Atypical Fibroxanthoma of the skin (AFX) is an uncommon tumor of sun-exposed areas of elderly white men, most commonly on the scalp and ears. This fibro-histiocytic spindle cell neoplasm has a potential to metastasize and behave aggressively. Diagnosis is made by immunohistochemistry. AFX is histologically indistinguishable from malignant fibrous histiocytoma (MFH); therefore, its clinical presentation must be used as a guide to its true behavior. Superficial lesions behave in a benign fashion and are called AFX, while lesions with subcutaneous extent or larger size have a higher tendency for lymph node and distant metastases and are called MFH. A corollary to the above also holds true. When regional metastases are found, the lesion is classified as MFH. Local recurrence can also be used to reclassify an AFX as a MFH. However, if the lesion “recurs” simply due to incomplete excision, its diagnosis should not be changed.

 

AFX has also been described as a superficial manifestation of MFH. Ronald Barr, M.D., (Dermatopathology) also believes that, comparing AFX to a superficial leimyosarcoma of the skin (SCARS Tumor Conference, 9/1/2011). The latter arises in piloerector muscles and behaves very differently than a deeper arising leiomyosarcoma that has a worse prognosis. As such, leimyosarcoma parallels behavior of AFX / MFH. A recent Mayo Clinic review of AFX found that 3.4% of these lesions transform into MFH or develop metastases within 2 years of treatment.

TREATMENT

Treatment of atypical fibroxanthoma of the skin (AFX) includes curettage and dessication (C&D), wide local excision (WLE), and Mohs micrographic surgery (MMS). Although all three are within the standard of care, the same Mayo clinic review found significant differences in recurrence rates. With Mohs micrographic surgery the recurrence was 0%, and with wide local excision it was 8.7%. WLE with 2 cm margins was recommended to ensure 96.6% clearance. However, MMS achieved cure with more tissue sparing.  A two-year follow-up is recommended after resection to monitor for regional metastases or recurrences.

 

Treatment of lesions that behave as MFH (metastatic and recurrent) is surgical resection followed by radiation therapy. The differential diagnosis for spindle cell neoplasm, such as AFX, includes spindle cell squamous cell carcinoma, dermatofibrosarcoma protuberans, and desmoplastic melanomas.

Related Articles

Evaluation of Longitudinal Melanonychia
HISTORY An 84-year-old woman with a history of melanoma of the left upper back presents with an 11 month h/o left great toe discoloration. Biopsy of left great toe was performed on 08/05/2019. Previous h/o discoloration of the right fifth toe was biopsied and was negative for malignancy. DISCUSSION What is the cause of melanonychia…
Read More
Intralesional 5-fluorouracil for Cutaneous BCC and SCC
HISTORY  An 86-year-old man on hemodialysis with multiple medical problems and on warfarin presented with two carcinomas of the nasal tip: BCC of the left nasal tip and SCC of the right nasal tip. The ulceration of the right SCC exposed the alar cartilage. Patient completed six (6) 5-fluorouracil injections over a 5-week period. Complete…
Read More
Nasal Open Wound Complication
HISTORY A 73-year-old man with BCC of the nasal tip presented 1 week following Mohs excision. His reconstruction was delayed for an additional week for a cardiac work up. Nasal reconstruction was performed with a superior extended nasal myocutaneous flap (SENMI flap) and nasal septal cartilage grafts. The patient developed nasal tip incisional discharge 1…
Read More
Sentinel Lymph Node Biopsy for Cutaneous SCC
HISTORY A 58-year-old kidney transplant recipient presented with a 6-month history of squamous cell carcinoma of the left scalp. This large lesion was adjacent to the scar of a previous carcinoma excision in 2014. Patient is on sirolimus for his kidney transplant performed in 1984. He has had multiple BCCs and SCCs of scalp, back,…
Read More
Near-Infrared Laser Lymphangiography Sentinel Lymph Node Biopsy for Melanoma
HISTORY A 61-year-old male presents for 1.5 cm malignant melanoma of left posterior shoulder invading to at least 1.2 mm (Clark’s Level IV) on a shave biopsy. Left shoulder melanoma was excised, and a left axillary sentinel lymph node was biopsied. Small focus of residual melanoma was found in the primary site, but none in…
Read More
Recurrent BCC of the External Ear After Radiation
HISTORY A 77-year-old man presents with 5-year history of infiltrative basal cell carcinoma (BCC) of the left ear fossa triangularis and root of helix. The area was originally treated with four weeks of radiation in 2014, complicated by temporary ulceration and healing with adhesion. When the area developed crusting a couple of years later, the…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.